Cargando…
Randomized Open Investigation Determining Steroid Dose in Severe COVID-19: The ROIDS-Dose Clinical Trial
Introduction Treatment with dexamethasone reduces mortality in patients with coronavirus disease 2019 (COVID-19) pneumonia requiring supplemental oxygen, but the optimal dose has not been determined. Objective To determine whether weight-based dexamethasone of 0.2 mg/kg is superior to 6 mg daily in...
Autores principales: | Rabascall, Carlos X, Lou, Becky X, Dhar, Sean, Hasan, Zubair, Fryman, Craig, Izard, Stephanie, Makaryus, Mina, Acharya, Sudeep, Mastroianni, Fiore, Kamper, Martin, Duenas, Sean, Gong, Jonathan, Shah, Dimple, Khanijo, Sameer, Ying, Daniel, Habibullah, Junaid, Kim, Dae Hyeon, Butzko, Ryan, Oks, Margarita, Birnbaum, Brian, Moore, Jonathan, Singh, Anup K, Quintero, Luis, Lau, Michael, Honigman, Jared, Hilewitz, Ayelet, Shah, Kruti, Simonson, Joseph, Agrawal, Abhinav, Frank, Matthew, Tsegaye, Adey, Narasimhan, Mangala, Greenberg, Harly, Hahn, Stella S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9720033/ https://www.ncbi.nlm.nih.gov/pubmed/36475114 http://dx.doi.org/10.7759/cureus.31086 |
Ejemplares similares
-
Randomised Controlled Trial of Particles Used in Uterine fibRoid Embolisation (PURE): Non-Spherical Polyvinyl Alcohol Versus Calibrated Microspheres
por: Das, Raj, et al.
Publicado: (2022) -
Pneumothorax in COVID-19 Acute Respiratory Distress Syndrome: Case Series
por: Wong, Kelvin, et al.
Publicado: (2020) -
Pulmonary Function Testing in Patients With E-Cigarette, or Vaping, Product Use-Associated Lung Injury
por: Wei, Xingyu, et al.
Publicado: (2021) -
Effective use of monoclonal antibodies for treatment of persistent COVID-19 infection in a patient on rituximab
por: Rabascall, Carlos X, et al.
Publicado: (2021) -
Comparison of Efficacy and Safety of Fixed Dose Combination of Rosuvastatin and Choline Fenofibrate to Fixed Dose Combination of Rosuvastatin and Fenofibrate in Patients of Mixed Dyslipidemia: A Randomized, Open-label, Multicentre Clinical Trial in Indian Population
por: Barkate, Hanmant, et al.
Publicado: (2018)